Filtered By:
Therapy: Neoadjuvant Therapy
This page shows you your search results in order of relevance. This is page number 18.
Order by Relevance | Date
Total 36353 results found since Jan 2013.
11C-acetate PET/MRI in bladder cancer staging and treatment response evaluation to neoadjuvant chemotherapy: a prospective multicenter study (ACEBIB trial)
To evaluate the accuracy of 11C-acetate Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) in bladder cancer (BC) staging and monitoring response to neoadjuvant chemotherapy (NAC).
Source: Cancer Imaging - August 2, 2018 Category: Radiology Authors: Antti Salminen, Ivan Jambor, Harri Merisaari, Otto Ettala, Johanna Virtanen, Ilmari Koskinen, Erik Veskimae, Jukka Sairanen, Pekka Taimen, Jukka Kemppainen, Heikki Minn and Peter J. Bostr öm Tags: Research article Source Type: research
Establishment and external validation of a prognostic model for predicting disease-free survival and risk stratification in breast cancer patients treated with neoadjuvant chemotherapy
Source: Cancer Management and Research - July 31, 2018 Category: Cancer & Oncology Tags: Cancer Management and Research Source Type: research
A successful case of neoadjuvant chemotherapy and radical hysterectomy during pregnancy for advanced uterine cervical cancer accompanied by neonatal erythroderma
Journal of Obstetrics and Gynaecology Research, EarlyView.
Source: Journal of Obstetrics and Gynaecology Research - July 25, 2018 Category: OBGYN Authors: Kayo
Kayahashi
,
Yasunari
Mizumoto
,
Subaru
Myojo
,
Yusuke
Mitani
,
Atsushi
Tajima
,
Hiroshi
Fujiwara Source Type: research
Predictive value of carcinoembryonic antigen and carbohydrate antigen 19-9 related to downstaging to stage 0 & ndash;I after neoadjuvant chemoradiotherapy in locally advanced rectal cancer
Source: Cancer Management and Research - August 29, 2018 Category: Cancer & Oncology Tags: Cancer Management and Research Source Type: research
Significance of circulating tumor cells in osteosarcoma patients treated by neoadjuvant chemotherapy and surgery
Source: Cancer Management and Research - September 9, 2018 Category: Cancer & Oncology Tags: Cancer Management and Research Source Type: research
Predictive and prognostic value of Matrix metalloproteinase (MMP) - 9 in neoadjuvant chemotherapy for triple-negative breast cancer patients
This study aimed to investigate the clinical utility of serum and histological MMP-9 detection during neoadjuvant chemotherapy (NAC) for triple-negative breast cancer (TNBC).
Source: BMC Cancer - September 21, 2018 Category: Cancer & Oncology Authors: Ruo-Xi Wang, Sheng Chen, Liang Huang and Zhi-Ming Shao Tags: Research article Source Type: research
Increased derived neutrophil-to-lymphocyte ratio and Breast Imaging-Reporting and Data System classification predict poor survival in patients with non-distant metastatic HER2+ breast cancer treated with neoadjuvant chemotherapy
Source: Cancer Management and Research - September 23, 2018 Category: Cancer & Oncology Tags: Cancer Management and Research Source Type: research
Locoregional recurrence-associated factors and risk-adapted postmastectomy radiotherapy for breast cancer staged in cT1-2N0-1 after neoadjuvant chemotherapy
Source: Cancer Management and Research - October 1, 2018 Category: Cancer & Oncology Tags: Cancer Management and Research Source Type: research
Predicting the response to neoadjuvant therapy for early-stage breast cancer: tumor-, blood-, and imaging-related biomarkers
Source: Cancer Management and Research - October 8, 2018 Category: Cancer & Oncology Tags: Cancer Management and Research Source Type: research
Platelet-to-lymphocyte ratio and lymphocyte-to-white blood cell ratio predict the efficacy of neoadjuvant chemotherapy and the prognosis of locally advanced gastric cancer patients treated with the oxaliplatin and capecitabine regimen
Source: OncoTargets and Therapy - October 16, 2018 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma
We have previously shown that podocalyxin-like protein (PODXL) is a prognostic biomarker for poor survival in gastric and esophageal adenocarcinoma treated with surgery up-front. The aim of the present study w...
Source: Journal of Translational Medicine - October 24, 2018 Category: Research Authors: David Borg, Anna H. Larsson, Charlotta Hedner, Bj örn Nodin, Anders Johnsson and Karin Jirström Tags: Research Source Type: research
Does baseline 18F FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer?
[18F] fluorodeoxyglucose positron emission tomography/computed tomography ([18F] FDG-PET/CT) may be used for tumor staging and prognosis in several tumors but its role in rectal cancer is still debated. The ai...
Source: Radiation Oncology - October 25, 2018 Category: Cancer & Oncology Authors: Letizia Deantonio, Angela Caroli, Erinda Puta, Daniela Ferrante, Francesco Apicella, Lucia Turri, Gianmauro Sacchetti, Marco Brambilla and Marco Krengli Tags: Research Source Type: research
Long-term effects of neoadjuvant radiotherapy, adjuvant radiotherapy, and chemotherapy-only on survival of locally advanced non-small cell lung Cancer undergoing surgery: a propensity-matched analysis
The optimal timing of radiotherapy (RT) with respect to surgery remains controversial for locally advanced non-small cell lung cancer (LA NSCLC) undergoing surgery and the long-term effect of neoadjuvant RT, a...
Source: BMC Cancer - November 6, 2018 Category: Cancer & Oncology Authors: Xinyu Wang, Chang Yin, Shaofei Su, Xi Li, Chao Wang, Chaoli Zhang and Meina Liu Tags: Research article Source Type: research
Pathological complete response after neoadjuvant pembrolizumab and radiation
Clinical and Experimental Dermatology, EarlyView.
Source: Clinical And Experimental Dermatology - November 7, 2018 Category: Dermatology Authors: J. N. Mynard,
R. M. Conry,
J. De Los Santos,
J. B. Gordetsky,
C. M. Contreras Tags: CPD ● Therapeutic vignette Source Type: research
Management of bone and metabolic effects of androgen deprivation therapy
Androgen Deprivation Therapy (ADT) has established roles in the neoadjuvant treatment of high risk localized prostate cancer (CaP) together with radiotherapy, and in biochemically recurrent nonmetastatic, and metastatic disease. Use of gonadotrophin-releasing hormone (GnRH) analogs as a means of blocking testosterone production is currently the most commonly used ADT modality. As long-term survival in men receiving ADT is the norm, it is appropriate to focus on identification and mitigation of adverse effects of this therapy.
Source: Urologic Oncology: Seminars and Original Investigations - November 13, 2018 Category: Urology & Nephrology Authors: Nicholas Russell, Mathis Grossmann Tags: Seminars Article Source Type: research
